222

SHANGHAI HENLIUS BIOTECH INC

No trades
See on Supercharts

2696 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. It operates through the Mainland China and Overseas geographical segments. The company was founded by Wei Dong Jiang and Shi Gao Liu in 2010 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2696 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company